Research Nester Logo.jpg
Pericardial Patches Market revenue to reach USD 604 Million by 2033, says Research Nester
August 24, 2023 05:30 ET | Research Nester
New York, Aug. 24, 2023 (GLOBE NEWSWIRE) -- The global pericardial patches market size is projected to grow at a CAGR of over ~7% from 2023 to 2033. The market is expected to garner a revenue of USD...
MicrosoftTeams-image (5).png
Pericardial Patches Market Size to Cross USD 604 million by 2031 growing at a 6.8%: TMR Report
July 04, 2023 12:30 ET | Transparency Market Research
Wilmington, Delaware, United States, July 04, 2023 (GLOBE NEWSWIRE) -- The global pericardial patches market is anticipated to grow at a 6.8% CAGR from 2023 to 2031. A market valuation of US$ 604...
Logo-Cellfbio-Tagline-400x400 (1).jpg
CELLF BIO Achieves Milestone With First In Human Implantation of BioSphincter™
June 06, 2023 16:27 ET | CELLF-BIO, LLC
RICHMOND, Va., June 06, 2023 (GLOBE NEWSWIRE) -- CELLF BIO achieved a major milestone with the world's first human implantation of BioSphincter™, an autologous bioengineered sphincter made of smooth...
TIP_link_300x300.jpg
Skin Graft Market (Product, Graft Thickness) - Reach $1.67Bn by 2028 at 7% CAGR with Autologous Segment Driving Growth During 2021–2028 | The Insight Partners
May 18, 2023 10:54 ET | The Insight Partners
Pune, India., May 18, 2023 (GLOBE NEWSWIRE) -- The Insight Partners published latest research report on "Skin Graft Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product, Graft...
Vaccentis CMO
Vaccentis Appoints Dr. Ingrid Rauter as Chief Medical Officer and Head of Research & Development
May 03, 2023 03:00 ET | Vaccentis AG
Zurich, Switzerland, May 3, 2023 - Vaccentis AG, a clinical-stage Swiss biopharmaceutical company developing patient-individualized medicines, today announced the appointment of the experienced life...
_76A4572
Vaccentis appoints Martin Munte as CEO and strengthens Board
July 12, 2022 02:00 ET | Vaccentis AG
Martin Munte has extensive leadership experience at Amgen, AstraZeneca and RocheStrengthening management after appointment of three new Board members Zurich, Switzerland, July 12, 2022 -...
_76A4572
Vaccentis stärkt Management durch Berufung von Martin Munte zum CEO
July 12, 2022 02:00 ET | Vaccentis AG
Pharmamanager mit langjährige Führungserfahrung bei Amgen, AstraZeneca und RocheWeitere Verstärkung des Managements nach Ernennung dreier neuer Mitglieder im Verwaltungsrat Zurich, Schweiz, 12....
Sm-logo-resized.jpg.png
Platelet Rich Plasma Market to reach 985 million in 2030 with a CAGR of around 12.12%, asserts Strategic Market Research
May 24, 2022 10:22 ET | STRATEGIC MARKET RESEARCH LLP
New York, United States, May 24, 2022 (GLOBE NEWSWIRE) -- Platelet-rich plasma (PRP) therapy utilizes the patient's platelets by loading its concentration in the injection to enhance the healing of...
researchdrivelogo.jpg
Global Plasma Therapy Market Predicted to Garner a Revenue of $432.8 Million at a CAGR of 16.3% during the Forecast Period, 2019-2026 - Exclusive report by Research Dive
July 26, 2021 09:03 ET | Research Dive
New York, USA, July 26, 2021 (GLOBE NEWSWIRE) -- According to a recent report by Research Dive, the global plasma therapy market is forecasted to reach $432.8 million by the end of 2026, from $131.9...
Reports and Data.jpeg-01
Stem Cell Manufacturing Market Size to Reach USD 28.85 Billion in 2028: Reports and Data
June 09, 2021 03:06 ET | Reports and Data
New York, June 09, 2021 (GLOBE NEWSWIRE) -- Major factors driving market revenue growth include increasing use of stem cells to treat various diseases, rising stem cell-based research activities,...